BIVI Biovie Inc
P/E
--
Forward P/E
--
Price/Sales
--
Beta
0.737
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🟢 Biovie is trading 6% up in after-hours trading after positive Phase 2 SUNRISE-PD results
Biovie is trading at $1.97, up +6.12%, after positive Phase 2 SUNRISE-PD results for bezisterim. - The results extended its sharp August 20, 2026 rally and...
Biovie Inc Q2 2026 Earnings Preview: What Analysts Expect on August 21, 2026
Analysts expect BioVie Inc. to report a consensus revenue of $0.00 and an EPS loss of $0.52 for the second calendar quarter of 2026. The current stock price of...
Biovie's Parkinson's Drug Clears a Key Hurdle — But Can a $10 Million Company Really Deliver on a Blockbuster Promise?
Shares of BioVie Inc. surged 34.3% to $1.80 on August 20 as investors circled back to positive Phase 2 data for bezisterim, its experimental Parkinson's...
🟢 Biovie is trading 34.33% up today after positive Phase 2 SUNRISE-PD results
Biovie is trading 34.33% up at $1.80 after renewed attention to positive Phase 2 SUNRISE-PD results for bezisterim. - The trial reportedly met its primary...